Why is Genpharmasec falling/rising?

As of 24-Sep, Genpharmasec Ltd's stock price is currently at 1.98, reflecting a decrease of 0.02, or 1.0%. The stock has been underperforming recently, having fallen consecutively for the last three days with a total decline of 3.88%. Today's performance shows that it underperformed its sector by 0.81%. Additionally, the stock's returns over the past week are positive at +3.66%, but it has seen a decline of 1.00% over the past month and a significant drop of 39.08% over the past year. Despite reporting a remarkable growth in operating profit of 2500% and positive quarterly results, the company faces long-term fundamental weaknesses, including a negative CAGR growth in operating profits over the last five years and a poor EBIT to interest ratio, which raises concerns about its financial stability.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has consistently underperformed against the BSE500 over the last three years, generating -39.08% returns compared to the benchmark's -3.77% in the same period. While the stock has shown some short-term recovery, the overall trend indicates a lack of investor confidence, evidenced by a significant drop in delivery volume by 59.4% against the five-day average. This decline in investor participation, combined with the company's ongoing financial challenges, suggests that the stock's recent price movement is primarily driven by negative sentiment and fundamental weaknesses rather than positive operational results.